Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance
Drug Resistance Updates · 2024-01 · 72 · 101013
DOI: 10.1016/j.drup.2023.101013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2024-01. Verfasst von Huize Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Cancer Hospital, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China; School of Phar…. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Cancer Hospital, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zh…
- Department of stomatology, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, China.
- Zhejiang Cancer Hospital, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China.
- Zhejiang Cancer Hospital, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China. Electronic address: yxf_1029@163.com.
- Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. Electronic address: jqin@ucas.ac.cn.
- Zhejiang Cancer Hospital, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China. Electronic address: liql@zjcc.org.cn.
Zitieren
APA
Shen, H., Zhu, R., Liu, Y., Hong, Y., Ge, J., Xuan, J., Niu, W., Yu, X., Qin, J. J., & Li, Q. (2024). Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance. Drug Resistance Updates, 72, 101013. https://doi.org/10.1016/j.drup.2023.101013
Vancouver
Shen H, Zhu R, Liu Y, Hong Y, Ge J, Xuan J, et al. Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance. Drug Resistance Updates. 2024;72:101013. doi:10.1016/j.drup.2023.101013
BibTeX
@article{Shen2024,
author = {Shen, Huize and Zhu, Rui and Liu, Yanyang and Hong, Yangjian and Ge, Jiaming and Xuan, Jie and Niu, Wenyuan and Yu, Xuefei and Qin, Jiang-Jiang and Li, Qinglin},
title = {Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance},
journal = {Drug Resistance Updates},
year = {2024},
volume = {72},
pages = {101013},
doi = {10.1016/j.drup.2023.101013}
}
EUVIMED